Literature DB >> 6407163

Interaction between doxorubicin and mitomycin C on mortality and myocardial contractility in guinea pig.

E Monti, R Bossa, I Galatulas, L Favalli, F Villani, F Piccinini.   

Abstract

The present investigations were carried out in guinea pig to ascertain whether mitomycin C has a direct cardiotoxic effect or interacts with doxorubicin-induced cardiotoxicity. I.p. administration of mitomycin C did not modify the survival rate up to 30 days, whereas the combined administration of doxorubicin and mitomycin C significantly decreased the survival time in comparison to the doxorubicin-treated group. On isolated atria, mitomycin C did not cause significant inhibition of the contractile force or an enhancement of the doxorubicin-induced negative inotropic effect. These results do not support the possibility that mitomycin C potentiates the acute cardiotoxic effects produced by doxorubicin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407163     DOI: 10.1177/030089168306900205

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  3 in total

1.  Possible enhancement of the cardiotoxicity of doxorubicin when combined with mitomycin C.

Authors:  F Villani; R Comazzi; G Lacaita; A Guindani; V Genitoni; A Volonterio; M C Brambilla
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

2.  A prospective study on the dose dependency of cardiotoxicity induced by mitomycin C.

Authors:  J Verweij; A J Funke-Küpper; G J Teule; H M Pinedo
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

3.  Cardiotoxicity of mitomycin A, mitomycin C, and seven N7 analogs in vitro.

Authors:  R T Dorr; N G Shipp; J D Liddil; B S Iyengar; K R Kunz; W A Remers
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.